Locations:
Search
While the retropubic approach is popular, is the perineal approach equally effective and less invasive?
Here’s why you should attend this two-day conference
The first approved treatment for men with nonmetastatic castration-resistant prostate cancer (M0CRPC)
Will new or improved modalities help patients accept more invasive treatment?
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Effective therapy is available, but underutilized
Following a father’s sage advice
It’s a win-win when APPs manage their own patients
Join us at the ASRM Conference Oct. 28-Nov. 1
Alternatives for condition affecting millions of men as they age
One-stop shop elevates access to complete care
Advertisement
Advertisement